InspireMD (NSPR) Restructuring Costs (2015 - 2025)
InspireMD (NSPR) posted quarterly Restructuring Costs of $1.3 million for Q4 2025, up 21.29% year-over-year from $1.1 million in Q4 2024, and down 29.02% quarter-over-quarter from $1.8 million in Q3 2025.
InspireMD (NSPR) Restructuring Costs (2015 - 2025) Analysis & Trends
InspireMD's Restructuring Costs history runs 3 years deep, the most recent figure standing at $1.3 million for Q4 2025.
- In Q4 2025, Restructuring Costs rose 21.29% year-over-year to $1.3 million; the TTM figure through Dec 2025 stood at $6.3 million (up 38.12% YoY), while the FY2025 annual figure was $6.4 million, up 37.72% from the prior year.
- Restructuring Costs for Q4 2025 stood at $1.3 million, down from $1.8 million in the prior quarter.
- The five-year high for Restructuring Costs was $1.8 million in Q3 2025, with the low at $1.1 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.19 Bn | 194.59 Bn | 7.27 Bn |
| 2 | Stryker | 129.95 Bn | 126.47 Bn | 4.50 Bn |
| 3 | Medtronic | 120.06 Bn | 110.84 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.14 Bn | 73.60 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.74 Bn | 48.49 Bn | 1.35 Bn |
| 6 | Dexcom | 34.60 Bn | 32.65 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.20 Bn | 32.10 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.46 Bn | 23.13 Bn | 4.55 Bn |
| 9 | Steris | 23.25 Bn | 22.77 Bn | 684.20 Mn |
| 10 | InspireMD | 58.54 Mn | 4.33 Mn | 1.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.30 Mn |
| Sep 30, 2025 | 1.83 Mn |
| Jun 30, 2025 | 1.68 Mn |
| Mar 31, 2025 | 1.49 Mn |
| Dec 31, 2024 | 1.07 Mn |
| Sep 30, 2024 | 1.14 Mn |
| Jun 30, 2024 | 1.20 Mn |
| Mar 31, 2024 | 1.15 Mn |
| Dec 31, 2015 | 18,000.00 |
| Sep 30, 2015 | 418,000.00 |
| Jun 30, 2015 | 32,000.00 |